Surgery Partners (SGRY) Cost of Revenue (2014 - 2026)

Surgery Partners has reported Cost of Revenue for 13 years, with the latest figure at $220.2 million in Q1 2026.

• Quarterly Cost of Revenue rose 2.04% year-over-year to $220.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $723.7 million (up 216.44% YoY) and the FY2025 annual result came in at $878.9 million, up 335.75% from the prior year.
• Cost of Revenue slipped to $220.2 million in Q1 2026 per SGRY's latest filing, from $239.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $239.2 million in Q4 2025 and troughed at -$388.2 million in Q4 2024.
• A 5-year average of $120.8 million and a median of $188.4 million in 2023 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue surged 405.09% in 2023, then slumped 298.87% in 2024.
• Over 5 years, Cost of Revenue stood at $191.4 million in 2022, then gained by 1.99% to $195.2 million in 2023, then plunged by 298.87% to -$388.2 million in 2024, then soared by 161.62% to $239.2 million in 2025, then declined by 7.94% to $220.2 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $220.2 million, $239.2 million, and $208.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.